Which autoantibody is NOT commonly associated with autoimmune type 1 diabetes?

Prepare for the Endocrine Disorder Test. Engage with multiple choice questions with hints and explanations, ensuring a thorough understanding of endocrine system concepts. Excel in your exam with confidence!

Multiple Choice

Which autoantibody is NOT commonly associated with autoimmune type 1 diabetes?

Explanation:
Autoimmune type 1 diabetes is marked by antibodies against beta-cell components, reflecting ongoing autoimmune attack on the insulin-producing cells. The most consistent and commonly tested markers are antibodies to GAD65, IA-2, and ZnT8. These reflect the autoimmune process directly and remain reliable indicators across age groups. Insulin autoantibodies often appear early, especially in very young children, but they become less specific once treatment begins because exposure to therapeutic insulin can provoke antibodies to insulin itself. This makes insulin autoantibodies a less reliable marker of the autoimmune process in established disease. Therefore, insulin autoantibody is not commonly used as a defining autoantibody in autoimmune type 1 diabetes.

Autoimmune type 1 diabetes is marked by antibodies against beta-cell components, reflecting ongoing autoimmune attack on the insulin-producing cells. The most consistent and commonly tested markers are antibodies to GAD65, IA-2, and ZnT8. These reflect the autoimmune process directly and remain reliable indicators across age groups. Insulin autoantibodies often appear early, especially in very young children, but they become less specific once treatment begins because exposure to therapeutic insulin can provoke antibodies to insulin itself. This makes insulin autoantibodies a less reliable marker of the autoimmune process in established disease. Therefore, insulin autoantibody is not commonly used as a defining autoantibody in autoimmune type 1 diabetes.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy